Evidence map›Paper›PMID 41070456›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2025

Epidemiology and risk factors of

Heikki Ilmavirta, Jukka Ollgren, Kati Räisänen, Tuure Kinnunen, Jari Jalava, Outi Lyytikäinen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Two Multidrug-ResistantPathogens (Basel, Switzerland) · 2026
    Article
  2. Risk factors for antibiotic resistance and 30-day mortality among adult patients with acute leukemia and Escherichia coli bloodstream infection.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Heikki IlmavirtaDepartment of Clinical Microbiology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
Jukka OllgrenDepartment of Public Health, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Kati RäisänenDepartment of Public Health, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Tuure KinnunenDepartment of Clinical Microbiology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
Jari JalavaDepartment of Public Health, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Outi LyytikäinenDepartment of Public Health, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND

Indexed as

Bacteremiabeta-LactamasesCross InfectionEscherichia coliEscherichia coli InfectionsAdolescentAdultAgedAged, 80 and overAnti-Bacterial AgentsChildChild, PreschoolFemaleFinlandHumansIncidenceAnti-Bacterial Agentsbeta-LactamasesBacteraemiaBloodstream infectionCase fatalityDrug resistance bacterialEpidemiologyEscherichia coliExtended-spectrum beta-lactamaseIncidence

Identifiers

PMID41070456
PMCPMC12514435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.